Mainz Biomed N.V. (QUCY) Stock Overview
Explore Mainz Biomed N.V.’s financial performance, market position, analyst ratings, and future outlook.
Mainz Biomed N.V. (QUCY)
Key Financials
Key Financials
Market Cap
20.4M
P/E Ratio
-3.80
EPS (TTM)
$-22.36
ROE
-2.44%
QUCY Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Mainz Biomed N.V. (QUCY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 44.78, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.80 and a market capitalization of 20.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.